Cargando…
Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
Friedreich ataxia (FRDA) is a rare neurological disorder due to deficiency of the mitochondrial protein frataxin. Frataxin deficiency results in impaired mitochondrial function and iron deposition in affected tissues. Erythropoietin (EPO) is a cytokine which was mostly known as a key regulator of er...
Autores principales: | Boesch, Sylvia, Indelicato, Elisabetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491891/ https://www.ncbi.nlm.nih.gov/pubmed/31105516 http://dx.doi.org/10.3389/fnins.2019.00386 |
Ejemplares similares
-
Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023) -
Body Mass Index and Height in Friedreich Ataxia: What Do We Know?
por: Boesch, Sylvia M., et al.
Publicado: (2021) -
A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia
por: Santner, Wolfram, et al.
Publicado: (2014) -
Autonomic function testing in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2018) -
Onset features and time to diagnosis in Friedreich’s Ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2020)